PLOD1 and neoplasm: Studies carried out employing inhibitors and dominant negative constructs of SFKs have shown that many of these molecules interact with the canonical LH/CGR activated signaling pathway resulting in altered responsiveness to steroidogenesis in ovarian cells [19,70,71], MA-10 tumor Leydig cells [18,72,73] and adrenal cells [74,75].